Literature DB >> 6419767

Toxicity of sphingomyelin-containing liposomes after chronic injection into mice.

E A Weereratne, G Gregoriadis, J Crow.   

Abstract

Chronic treatment (10 i.p. injections over 20 days) of Balb/c mice with SM liposomes led to 50 and 300% enlargement of the liver and spleen respectively. No such effect was observed after similar treatment with PC liposomes. Biochemical analysis of the enlarged tissues showed no significant changes in the concentrations of glycolipid, phospholipid and certain hydrolytic enzymes. However, the increase in tissue size was paralleled by an increase in protein content. Light and electron microscopy studies of the enlarged tissues revealed an increase in the number of Kupffer cells and collections of inflammatory cells in the liver and widespread granulomatous inflammation in the spleen. We conclude that SM liposomes, although probably toxic for use as a drug carrier, may serve as a model agent in the study of tissue granulomatous inflammation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6419767      PMCID: PMC2040830     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  13 in total

1.  Rapid partial purification of placental glucocerebroside beta-glucosidase and its entrapment in liposomes.

Authors:  I P Braidman; G Gregoriadis
Journal:  Biochem J       Date:  1977-05-15       Impact factor: 3.857

2.  Targeting of drugs: implications in medicine.

Authors:  G Gregoriadis
Journal:  Lancet       Date:  1981-08-01       Impact factor: 79.321

3.  Is half-life of circulating liposomes determined by changes in their permeability?

Authors:  J Senior; G Gregoriadis
Journal:  FEBS Lett       Date:  1982-08-16       Impact factor: 4.124

4.  Plasma-induced release of solutes from small unilamellar liposomes is associated with pore formation in the bilayers.

Authors:  C Kirby; G Gregoriadis
Journal:  Biochem J       Date:  1981-10-01       Impact factor: 3.857

5.  Response of sphingolipid hydrolases in spleen and liver to increased erythrocytorhexis.

Authors:  J P Kampine; J N Kanfer; A E Gal; R M Bradley; R O Brady
Journal:  Biochim Biophys Acta       Date:  1967-02-14

6.  Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro.

Authors:  C Kirby; J Clarke; G Gregoriadis
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

7.  Effects of liposome size on the degradation of bovine brain sphingomyelin/cholesterol liposomes in the mouse liver.

Authors:  P L Beaumier; K J Hwang
Journal:  Biochim Biophys Acta       Date:  1983-05-26

8.  Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation.

Authors:  F Szoka; D Papahadjopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

9.  Quantitative determination of the neutral glycosyl ceramides in human blood.

Authors:  D E Vance; C C Sweeley
Journal:  J Lipid Res       Date:  1967-11       Impact factor: 5.922

10.  Screening for urinary oligosaccharides: a quantitative procedure.

Authors:  P Purkiss; R C Hughes; R W Watts
Journal:  Clin Chem       Date:  1978-04       Impact factor: 8.327

View more
  2 in total

1.  Effects of chronic injection of sphingomyelin-containing liposomes on lymphoid and non-lymphoid cells in the spleen. Transient suppression of marginal zone macrophages.

Authors:  E Claassen; Y Westerhof; B Versluis; N Kors; M Schellekens; N van Rooijen
Journal:  Br J Exp Pathol       Date:  1988-12

2.  Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models.

Authors:  M S Webb; T O Harasym; D Masin; M B Bally; L D Mayer
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.